2019 IQ CPLG and TALG FDA Meeting

October 15, 2019

On 15 October 2019, the IQ Clinical Pharmacology Leadership Group (CPLG) and Translational and ADME Sciences Leadership Group (TALG) was honored to participate in a scientific exchange meeting with the FDA Office of Clinical Pharmacology.  IQ presented on, and discussed, cell and gene therapies, and participated in roundtable discussions with FDA on the Model-Informed Drug Development (MIDD) pilot program and Physiologically Based Pharmacokinetic (PBPK) modeling for food effects.